JP Patent

JP7338950B2 — （ｓ）－［３，４－ジフルオロ－２－（２－フルオロ－４－ヨードフェニルアミノ）フェニル］［３－ヒドロキシ－３－（ピペリジン－２－イル」）アゼチジン－１－イル］－メタノンの結晶性フマル酸塩

Assigned to エクセリクシス， インク． · Expires 2023-09-05 · 3y expired

What this patent protects

Patent listed against cobimetinib-fumarate.

Drugs covered by this patent

Patent Metadata

Patent number
JP7338950B2
Jurisdiction
JP
Classification
—
Expires
2023-09-05
Drug substance claim
No
Drug product claim
No
Assignee
エクセリクシス， インク．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.